Abigail Pharma Private Limited
Founded in 2019 and headquartered in Uttar Pradesh, India.
2019 | Lucknow, Uttar Pradesh (India) | Active
Abigail Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
About Abigail Pharma
Abigail Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 September 2019 (Five years and five months 12 days old ). Its registered office is in Lucknow, Uttar Pradesh, India.
The Corporate was formerly known as Abigail Pharma Privare Limited. The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anuradha Pathak, Suman Rani, Meenakshi Srivastava, and One other member serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909UP2019PTC121338
- Company No.
121338
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Sep 2019
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Trading
Other Industry
Who are the key members and board of directors at Abigail Pharma?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anuradha Pathak  | Director | 27-Jul-2020 | Current |
| Suman Rani | Director | 27-Jul-2020 | Current |
| Meenakshi Srivastava | Director | 17-Sep-2019 | Current |
| Subodh Srivastava | Director | 17-Sep-2019 | Current |
Financial Performance of Abigail Pharma.
Enhance accessibility to Abigail Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Abigail Pharma?
Unlock access to Abigail Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Mid Kampf Pharmaceuticals Private Limited
Suman Rani is a mutual person
- Abigail Scientific Private Limited
Meenakshi Srivastava and Subodh Srivastava are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Abigail Pharma?
Unlock and access historical data on people associated with Abigail Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abigail Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abigail Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.